Results for tag: "Bone Sarcoma Drug"

Bone Sarcoma is a type of cancer that affects the bones and soft tissues. It is a rare form of cancer, accounting for less than 1% of all cancers. Treatment for bone sarcoma typically involves a combination of surgery, chemotherapy, and radiation therapy. Oncology drugs are used to treat bone sarcoma, including targeted therapies, immunotherapies, and hormone therapies. These drugs are designed to target specific cancer cells, while minimizing the damage to healthy cells. The Bone Sarcoma Drug market is a rapidly growing segment of the Oncology Drug market. It is driven by the increasing prevalence of bone sarcoma, as well as the development of new and innovative treatments. The market is expected to continue to grow in the coming years, as new treatments are developed and approved. Some companies in the Bone Sarcoma Drug market include Novartis, Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more